.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
Medtronic
Teva
Healthtrust
Mallinckrodt
UBS
Baxter
McKesson
AstraZeneca

Generated: July 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070051

« Back to Dashboard
NDA 070051 describes BETAMETHASONE VALERATE, which is a drug marketed by Taro Pharm, Perrigo Uk Finco, Riconpharma Llc, Actavis Mid Atlantic, Sti Pharma Llc, Perrigo New York, Pharmaderm, Fougera, Taro, Teva Pharms, and Pharmafair, and is included in eighteen NDAs. It is available from thirteen suppliers. Additional details are available on the BETAMETHASONE VALERATE profile page.

The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.

Summary for NDA: 070051

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 070051

Suppliers and Packaging for NDA: 070051

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE VALERATE
betamethasone valerate
OINTMENT;TOPICAL 070051 ANDA Actavis Pharma, Inc. 0472-0371 0472-0371-15 1 TUBE in 1 CARTON (0472-0371-15) > 15 g in 1 TUBE
BETAMETHASONE VALERATE
betamethasone valerate
OINTMENT;TOPICAL 070051 ANDA Actavis Pharma, Inc. 0472-0371 0472-0371-45 1 TUBE in 1 CARTON (0472-0371-45) > 45 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrengthEQ 0.1% BASE
Approval Date:Oct 10, 1984TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Harvard Business School
Argus Health
Boehringer Ingelheim
Accenture
Mallinckrodt
UBS
Chubb
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot